Fundz

Abpro Corp reported raising $10 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEApr 07, 2017$10M of $30M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Apr 7, 2017)

Round Type

Venture

WoburnBiotechnology

Quick answer

Abpro Corp raised $10 Million in a funding round, dated April 7, 2017. Abpro Corp is based in Woburn, Massachusetts, United States.

How much did Abpro Corp raise?
Abpro Corp raised $10 Million in a funding round on April 7, 2017.
What does Abpro Corp do?
Abpro Corporation is a biotechnology company with a mission to improve the lives of those facing severe and life-threatening diseases with next-generation antibody therapies.
Where is Abpro Corp based and how big is it?
Abpro Corp is based in Woburn, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Abpro Corp that raised within 45 days of this round, from Fundz verified event records.

  • ACTAVALON, INC. raised an undisclosed amount on May 22, 2017.
  • HEMOSHEAR THERAPEUTICS, LLC raised $300K (Seed) on May 22, 2017.
  • Siwa Corp raised $1.6M (Seed) on May 22, 2017.
  • Xeris Biopharma Holdings raised $30M on May 22, 2017.
  • Clinical Sensors, Inc. raised $200K (Pre-Seed) on May 19, 2017.
  • ONL Therapeutics raised $2.6M (Seed) on May 19, 2017.

Who to call at Abpro Corp, and when

A new round usually means Abpro Corp is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Abpro Corp raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Abpro Corp, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Abpro Corp. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Abpro Corp

Location

68 CUMMINGS PARK DRIVE

Woburn, Massachusetts, United States

About

Abpro Corporation is a biotechnology company with a mission to improve the lives of those facing severe and life-threatening diseases with next-generation antibody therapies. It is currently in the developmental phase of its next-generation antibody therapies, focusing on HER2+ cancer treatments, including breast, gastric and colorectal cancers, in addition to treatments for Wet AMD/DME and COVID-19.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Abpro Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Abpro Corp's next move

See what Strategic adds

Abpro Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.